A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients-Reference-Cited by-同舟云学术

A Cross-Sectional Study Comparing the Frequency of Drug Interactions After Adding Simeprevir- or Sofosbuvir-Containing Therapy to Medication Profiles of Hepatitis C Monoinfected Patients

Published:2015-01-28 Issue:1 Volume:4 Page:67-78
ISSN:2193-8229
Container-title:Infectious Diseases and Therapy
language:en
Short-container-title:Infect Dis Ther

Author:

Patel Nimish,Nasiri Mona,Koroglu Arden,Bliss Steven,Davis Melissa,McNutt Louise-Anne,Miller Christopher

Publisher

Springer Science and Business Media LLC

Subject

Infectious Diseases,Microbiology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40121-015-0058-x

Reference18 articles.

1. Olysio (simeprevir) tablet package insert. Titusville: Janssen Therapeutics, Division of Janssen Products, LP; 2013.

2. Sovaldi (sofosbuvir) package insert. Foster City: Gilead Sciences; 2013.

3. Recommendations for Testing, Managing, and Treating Hepatitis C. American Association for the Study of Liver Diseases/Infectious Diseases Society of America, with International Antiviral Society–USA. http://www.hcvguidelines.org/full-report-view . Accessed Sept 1, 2014.

4. Greene M, Steinman MA, McNicholl IR, Valcour V. Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection. J Am Geriatr Soc. 2014;62(3):447–53.

5. Centers for Disease Control & Prevention. Division of Viral Hepatitis. Surveillance for Viral Hepatitis—United States, 2011. http://www.cdc.gov/hepatitis/Statistics/2011Surveillance/index.htm . Accessed Sept 1, 2014.

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Drug safety in hospitalized patients with tuberculosis: Drug interactions and adverse drug effects;The Clinical Respiratory Journal;2020-10-12

2. Potential drug–drug interactions associated with adverse clinical outcomes and abnormal laboratory findings in patients with malaria;Malaria Journal;2020-08-31

3. Frequency of Potential Drug–Drug Interactions in the Changing Field of HCV Therapy;Open Forum Infectious Diseases;2020-02-01

4. Potential Drug-Drug Interactions in Patients With Urinary Tract Infections: A Contributing Factor in Patient and Medication Safety;Frontiers in Pharmacology;2019-09-17

5. Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients;Annals of Hepatology;2019-07